Atlantic Edge Private Wealth Management’s AstraZeneca AZN Stock Holding History

Atlantic Edge Private Wealth Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$39.3K	Hold	207	–	–	0.01%	277
2026 Q1	$40.8K	Sell	207 -1	-0.5%	-$193	0.01%	255
2025 Q4	$38.2K	Hold	208	–	–	0.01%	249
2025 Q3	$31.8K	Hold	208	–	–	0.01%	256
2025 Q2	$29K	Hold	208	–	–	0.01%	252
2025 Q1	$30.5K	Hold	208	–	–	0.01%	235
2024 Q4	$27.2K	Hold	208	–	–	0.01%	244
2024 Q3	$32.3K	Hold	208	–	–	0.01%	228
2024 Q2	$32.4K	Hold	208	–	–	0.01%	221
2024 Q1	$28.1K	Sell	208 -53	-20%	-$7.02K	0.01%	229
2023 Q4	$35.1K	Buy	+261	New	+$33.9K	0.01%	203

Other funds holding AZN

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

CDDEC

Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

BTCPP

Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Atlantic Edge Private Wealth Management's AZN Position: Q2 2026 in Review

Atlantic Edge Private Wealth Management held its AstraZeneca (AZN) position steady in Q2 2026 at 207 shares worth $39.3K. The position accounts for 0.01% of the portfolio, ranked #277.

Atlantic Edge Private Wealth Management first reported a position in AZN in Q4 2023 and has held it in 11 quarters since. The position peaked at $40.8K in Q1 2026. 574 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Atlantic Edge Private Wealth Management held 207 shares of AstraZeneca worth $39.3K as of Q2 2026.
Atlantic Edge Private Wealth Management left its AstraZeneca share count unchanged in Q2 2026.
AstraZeneca made up 0.01% of Atlantic Edge Private Wealth Management's portfolio in Q2 2026, its #277 holding.
Atlantic Edge Private Wealth Management first reported a position in AstraZeneca in Q4 2023 and has held it in 11 quarters since.
Atlantic Edge Private Wealth Management's AstraZeneca position peaked at $40.8K in Q1 2026.
574 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Atlantic Edge Private Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.